Finance

Lists
Why is SAILIFE down 3,75%?
Dive Deeper
SAILIFE:NSE
Sai Life Sciences Ltd
1 503,20 INR
-3,75%
(-58,60) 1D
8-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SAILIFE...
Open
1 563,40 INR
High
1 563,40 INR
Low
1 499,00 INR
Mkt. cap
313,71 млд
Avg. vol.
737,90 миң
Volume
513,98 миң
P/E ratio
88,44
52-wk high
1 697,00 INR
52-wk low
783,85 INR
EPS
17,00 INR
No. of employees
5 миң
Open
1 563,40 INR
High
1 563,40 INR
Low
1 499,00 INR
Mkt. cap
313,71 млд
Avg. vol.
737,90 миң
Volume
513,98 миң
P/E ratio
88,44
52-wk high
1 697,00 INR
52-wk low
783,85 INR
EPS
17,00 INR
No. of employees
5 миң
News stories
From web sources and news partners
Profile
Sai Life Sciences Limited is an Indian contract research, development, and manufacturing organisation, headquartered in Hyderabad, Telangana. The company provides drug discovery, development, contract manufacturing services for small-molecule new chemical entities to pharmaceutical and biotechnology companies. The company was established in Hyderabad in January 1999 as Sai Dru Syn Laboratories Limited. It was later renamed Sai Life Sciences Limited. It operates R&D and manufacturing facilities in India, the UK, and the USA. Wikipedia
About Sai Life Sciences Ltd
CEO-
Employees5,22 миң
Founded1999
Headquarters-
SectorHealth care
Last report
2026-ж., 7-авг.
Fiscal period
Q1 2027
3,42 INR / 3,60 INR
-5,00%miss
Revenue / Est. (INR)
5,54 млд / 5,65 млд
-1,84%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
5,37 млд
5,56 млд
6,02 млд
5,54 млд
Cost of goods sold
1,40 млд
1,28 млд
2,27 млд
1,45 млд
Cost of revenue
1,40 млд
1,28 млд
2,27 млд
1,45 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,63 млд
1,73 млд
1,96 млд
1,80 млд
Operating expense
2,91 млд
2,85 млд
2,43 млд
3,07 млд
Total operating expenses
4,31 млд
4,13 млд
4,70 млд
4,52 млд
Operating income
1,06 млд
1,44 млд
1,32 млд
1,02 млд
Other non operating income
153,25 млн
83,80 млн
-333,80 млн
35,43 млн
EBT including unusual items
1,12 млд
1,34 млд
1,39 млд
979,74 млн
EBT excluding unusual items
1,12 млд
1,42 млд
1,39 млд
979,74 млн
Income tax expense
282,07 млн
337,91 млн
349,91 млн
246,89 млн
Effective tax rate
25,17%
25,19%
25,13%
25,20%
Other operating expenses
887,29 млн
676,72 млн
14,63 млн
814,72 млн
Net income
838,44 млн
1,00 млд
1,04 млд
732,85 млн
Net profit margin
15,60%
18,04%
17,31%
13,22%
Earnings per share
3,93
5,00
4,86
3,42
Interest and investment income
-
-
186,18 млн
-
Interest expense
-93,51 млн
-96,99 млн
-78,25 млн
-76,36 млн
Net interest expenses
-93,51 млн
-96,99 млн
107,93 млн
-76,36 млн
Depreciation and amortization charges
397,48 млн
440,75 млн
453,08 млн
459,37 млн
EBITDA
1,45 млд
1,66 млд
1,60 млд
1,44 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору